Eyes On The Prize: The Latest Developments in Retinal Gene Therapies

This article will discuss some of the most promising gene therapies for age-related macular degeneration, including ADVM-022, RGX-314, GT-005, and HMR59.

Source: Forbes.com Healthcare News - June 26, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news